To evaluate the effectiveness and safety of mycophenolate mofetil (MMF) as first‐line therapy combined with systemic corticosteroids in initial‐onset acute uveitis associated with Vogt–Koyanagi–Harada (VKH) disease. Click to show full abstract
To evaluate the effectiveness and safety of mycophenolate mofetil (MMF) as first‐line therapy combined with systemic corticosteroids in initial‐onset acute uveitis associated with Vogt–Koyanagi–Harada (VKH) disease.
               
Click one of the above tabs to view related content.